Patent holdings for IPC class A61K 31/683

Total number of patents in this class: 535

10-year publication summary

52
58
50
51
49
38
20
30
16
3
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2167
31
Achillion Pharmaceuticals, Inc.
162
24
N.V. Nutricia
1084
22
SignPath Pharma Inc.
69
16
Aker Biomarine Human Ingredients AS
104
15
Société des Produits Nestlé S.A.
9946
9
Viking Therapeutics, Inc.
59
7
Nutritional Therapeutics, Inc.
15
6
Tasly Pharmaceutical Group Co., Ltd.
120
6
Kao Corporation
5023
5
Acasti Pharma Inc.
8
5
National Jewish Health
169
5
Nippon Suisan Kaisha, Ltd.
194
5
SRX Cardio, LLC
20
5
Janssen Sciences Ireland Unlimited Company
384
5
Merck Sharp & Dohme LLC
3726
5
Arctic Bioscience AS
8
5
Tecton Bg, Inc.
9
5
Johnson & Johnson Vision Care, Inc.
1185
4
Attillaps Holdings
14
4
Other owners 346